Oligonucleotide constructs and uses thereof

Immune adjuvant for cancer

RNA containing composition for treatment of tumor diseases

Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereof

Compositions and methods for antigen targeting to CD180

Immunogenic peptide containing a b cell epitope of tumor associated antigen L6

COMBINATION THERAPY WITH CPG TLR9 LIGAND

Scaffolded HIV-1 vaccine immunogens

Scaffolds for cell transplantation

Compositions of phosphorylated tau peptides and uses thereof

Complex containing oligonucleotide having immunopotentiating activity and use thereof

Substitutions-modified prefusion RSV F proteins and their use

MDR specific antibody

CpG-oligodeoxynucleotide, immunogenic composition including the same, and method of inducing immune response by the same

Method for treating melanoma using lymphangiogenesis inducers and a melanoma-specific antigen

Computationally optimized broadly reactive antigens for human and avian H5N1 influenza

Composition comprising PIC for treatment of cancer

HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS

AQUAPORIN TOLERIZING VACCINES AND METHODS OF USE THEREOF

Individualized vaccines for cancer

IMMUNOSTIMULATORY COMBINATIONS

INJECTABLE PREFORMED MACROSCOPIC 3-DIMENSIONAL SCAFFOLDS FOR MINIMALLY INVASIVE ADMINISTRATION

Immunotherapy against melanoma and other cancers

Compositions and methods for activating “stimulator of interferon gene”-dependent signalling

FcRn-targeted mucosal vaccination against RSV

Stabilized human immunodeficiency virus (HIV) envelope (ENV) trimer vaccines and methods of using same

RNA containing composition for treatment of tumor diseases

Nanoparticles, controlled-release dosage forms, and methods for delivering an immunotherapeutic agent

Methods of treating cancer cells expressing tumor-associated integrins

Albumin binding peptide conjugates and methods thereof

Fc RECEPTOR-MEDIATED DRUG DELIVERY

Immunotherapy against melanoma and other cancers

Immunotherapy against melanoma and other cancers

Immunotherapy against melanoma and other cancers

Immunotherapy against melanoma and other cancers

Oil-based adjuvants

Prostate-associated antigens and vaccine-based immunotherapy regimens

Means and methods for treating HBV

Individualized Immunomodulation Therapy for Neurodegenerative Disorders, CNS Injury and Age-Related Dementia

Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants

NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS

NEGATIVELY CHARGED NUCLEIC ACID COMPRISING COMPLEXES FOR IMMUNOSTIMULATION

Adjuvant compositions

Methods and vaccines for inducing immune responses to multiple different MHC molecules

Naturally-occurring CpG oligonucleotide compositions and therapeutic applications thereof

Vectors for expression of prostate-associated antigens

Linear chimeric compounds and methods of use thereof

Vaccination with MICA/B alpha 3 domain for the treatment of cancer

Composition and therapeutic anti-tumour vaccine

Mesoporous silica compositions comprising inflammatory cytokines comprising inflammatory cytokines for modulating immune responses

Vaccines against Zika virus based on Zika structure proteins

Adjuvanting systems and water-free vaccine compositions comprising a polyI:C polynucleotide adjuvant and a lipid-based adjuvant

Enhanced immune response in porcine species

CD200 inhibitors and methods of use thereof

Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use

Prefusion RSV F proteins and their use

STAT3 inhibitors and uses thereof

Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use

MATERIALS AND METHODS FOR MODULATING IMMUNE RESPONSES

Cell surface anchoring antigen conjugates to treat cancer

Multimeric fusion protein vaccine and immunotherapeutic

METHOD FOR PREPARING VIRAL PARTICLES WITH CYCLIC DINUCLEOTIDE AND USE OF SAID PARTICLES FOR INDUCING IMMUNE RESPONSE

Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate

HIV pre-immunization and immunotherapy

Method for improving the efficacy of a survivin vaccine in the treatment of cancer

Molecular adjuvant and vaccine

Method of eliciting an anti-tumor immune response with controlled delivery of TLR agonists in porous polymerlc devices

Systems and methods for nucleic acid expression in vivo

Polymer conjugate vaccines

Devices for supporting regeneration of body tissues, and methods of making and using them

Particles comprising a shell with RNA

Nucleic acid derivative having immunostimulatory activity

Foot-and-mouth disease vaccine

IMMUNOMODULATORY AGENT-POLYMERIC COMPOUNDS

COMPOSITIONS AND METHODS FOR INDUCING AND ENHANCING AN IMMUNE RESPONSE

Synthetic conjugate of CpG DNA and T-help/CTL peptide

Methods and compositions for eliciting an immune response against hepatitis B virus

Injectable Cryogel Vaccine Devices and Methods of Use Thereof

Compounds and Methods for the Treatment of Inflammatory Diseases of the CNS

Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy

Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant

TREATMENT OF CANCER WITH THERAPEUTIC MONOCLONAL ANTIBODY SPECIFIC FOR A TUMOR ASSOCIATED ANTIGEN AND AN IMMUNE ADJUVANT

RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES

Methods and compositions for treating cancers using antisense

Immunotherapy against melanoma and other cancers

Stabilized human immunodeficiency virus (HIV) envelope (ENV) trimer vaccines and methods of using same

Allogeneic autophagosome-enriched composition for the treatment of disease

Immunoglobulin single variable domain antibody against RSV prefusion F protein

Adjuvant for vaccines, vaccine, and immunity induction method

Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment

Allogeneic autophagosome-enriched composition for the treatment of disease

Immunogenic compositions comprising polypeptides and fusions thereof

Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer

Vaccine adjuvant composition comprising inulin particles

Methods and compositions for stimulating immune response using potent immunostimulatory RNA motifs

METHODS FOR POTENTIATING AN IMMUNE RESPONSE USING DEPOT-FORMING AND NON-DEPOT-FORMING VACCINES

Liposome-peptide conjugate and method of using same to induce production of anti-HIV antibodies

Methods for treating tumors in situ including intratumor injection of cytotoxic particles and immune checkpoint blockade therapy

Method of stimulating TLR9-activated immune response

Lipids and compositions for the delivery of therapeutics

HIV immune stimulating compositions comprising recombinantly expressed pili on bacteria and methods related thereto

PLACENTAL VACCINATION THERAPY FOR CANCER

Her2/neu immunogenic composition

Prime-boost regimens involving administration of at least one mRNA construct

Immunostimulatory compositions, particles, and uses related thereto

Functional influenza virus like particles (VLPs)

Method of providing patient specific immune response in amyloidoses and protein aggregation disorders

Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling

Bacterial minicells for delivering nucleic acid adjuvants and methods of using the same

Methods to improve induction of IgA antibodies by vaccines

Lipids and compositions for the delivery of therapeutics

CHLAMYDIA ANTIGENS

Cyclic dinucleotide compounds

Optimized cancer stem cell vaccines

Hepatitis B therapeutic vaccines

Vaccine formulation, preparation method therefor and use thereof

IMMUNOMODULATORY COMPOSITIONS COMPRISING A POLYMER MATRIX AND AN OIL PHASE

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

Polypeptides and immunizing compositions containing polypeptides and methods of use

Method of developing a vaccine using peptide-poly IC complexes

Display platform from bacterial spore coat proteins

PCI method for generating immune respose to antigenic molecule using checkpoint inhibitor and TLR3 ligand

DOSE SELECTION OF ADJUVANTED SYNTHETIC NANOCARRIERS

Lipids and compositions for the delivery of therapeutics

Polyelectrolyte multilayers assembled from immune signal compounds

Liposomal adjuvant compositions

In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus-Like Particles

HIV pre-immunization and immunotherapy

CD200 inhibitors and methods of use thereof

Methods and compositions for induction of immune response

COMPOSITIONS AND METHODS RELATED TO NEUROLOGICAL DISORDERS

Tuberculosis compositions and methods of treating or preventing tuberculosis

Immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants

RECOMBINANT H7 HEMAGGLUTININ AND USE THEREOF

A Rabies Composition Comprising Pika Adjuvant

Compositions and methods for activating “stimulator of interferon gene”-dependent signalling

Immunotherapy against several tumors including neuronal and brain tumors

Immunotherapy against melanoma and other cancers

Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses

TH1-inducing adjuvant comprising combination of different nucleic acid adjuvants, and use of same

Modified virus-like particles of CMV

MODULATION OF NKT CELL ACTIVITY WITH ANTIGEN-LOADED CD1d MOLECULES

Adjuvant compositions

VACCINE COMPOSITIONS AND METHODS OF USE TO TREAT NEONATAL SUBJECTS

Acid-degradable and bioerodible modified polyhydroxylated materials

Compositions and methods for enhanced innate immunity

THERMOSTABLE, CHROMATOGRAPHICALLY PURIFIED NANO-VLP VACCINE

5′-triphosphate oligoribonucleotides

Particles comprising single stranded RNA and double stranded RNA for immunomodulation

Compositions including beta-glucans and method of use

Lipid vesicle compositions and methods of use

Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant

Methods and compositions for vaccinating a subject for a sexually transmitted pathogen

Pathogen vaccines and methods of producing and using the same

Immunogenic polypeptide cocktail for the treatment of medullary thyroid carcinoma

COMPOSITIONS AND METHODS RELATED TO NEUROLOGICAL DISORDERS

SMC combination therapy for the treatment of cancer

Recombinant HIV-1 envelope proteins and their use

Interferon therapy

Tumor antigen specific antibodies and TLR3 stimulation to enhance the performance of checkpoint interference therapy of cancer

SYNERGISTIC TUMOR TREATMENT WITH IL-2, A THERAPEUTIC ANTIBODY, AND A CANCER VACCINE

IMMUNOSTIMULATION BY CHEMICALLY MODIFIED RNA

VACCINE DELIVERY METHOD

In situ antigen-generating cancer vaccine

RNA-based compositions and adjuvants for prophylactic and therapeutic treatment

IMMUNOSTIMULATORY COMBINATIONS OF TLR LIGANDS AND METHODS OF USE

Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications

AGONISTS AND ANTAGONISTS OF TOLL-LIKE RECEPTOR (TLR) 13

Stabilised formulations of RNA

RNA vaccines

Pharmaceutical compositions comprising CpG oligonucleotides

SACCHARIDE VACCINE FORMULATION

Computationally optimized broadly reactive antigens for human and avian H5N1 influenza

Methods and compositions for eliciting an immune response against hepatitis B virus

MDR specific antibody

Medicament for use in a method of inducing or extending a cellular cytotoxic immune response

Medicament for use in a method of inducing or extending a cellular cytotoxic immune response

Compositions for stimulation of mammalian innate immune resistance to pathogens

SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION

Nanoparticle compositions

Immunogenic peptides for treatment of herpes simplex virus infection and conditions

Vaccine delivery systems using yeast cell wall particles

Combination vaccine devices and methods of killing cancer cells

COMPOSITIONS HAVING MEANS FOR TARGETING AT LEAST ONE ANTIGEN TO DENDRITIC CELLS

Guanosine as an immune potentiator mediated through toll receptors

SPECIFIC VIRUS-LIKE PARTICLE-CpG OLIGONUCLEOTIDE VACCINES AND USES THEREOF

Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates

DNA vaccines and methods for the prevention of transplantation rejection

ANTI-TUMOR COMPOSITIONS AND USES THEREOF

Vaccine compositions

Peptide/β-1,3-glucan complex and production method thereof and pharmaceutical composition containing peptide/β-1,3-glucan complex

Multivalent stable vaccine composition and methods of making same

COMPOSITIONS AND METHODS FOR INDUCING AN ENHANCED IMMUNE RESPONSE USING POXVIRUS VECTORS

Immunotherapy against several tumors including neuronal and brain tumors

Immunotherapy against several tumors including neuronal and brain tumors

Immunotherapy against several tumors including neuronal and brain tumors

Immunotherapy against several tumors including neuronal and brain tumors

Immunotherapy against several tumors including neuronal and brain tumors

Homogenous suspension of immunopotentiating compounds and uses thereof

Lipid nanoparticle vaccine adjuvants and antigen delivery systems

Compositions and methods for modulating an immune response

Covalently closed non-coding immunomodulatory DNA construct

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

T20 constructs for anti-HIV (human immunodeficiency virus) therapy and/or vaccines

Type III secretion injectisome proteins for treatment and prevention of chlamydial infections

Combination therapy with neoantigen vaccine

STAT3 inhibitors and uses thereof

Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator

RNA containing composition for treatment of tumor diseases

Chiral nucleic acid adjuvant having antitumor effect and antitumor agent

Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent

Composition and therapeutic anti-tumour vaccine

Programming of cells for tolerogenic therapies

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

Double-stranded polyC:poly(G/I) RNA for immunostimulation and cancer treatment

Lipid vesicle compositions and methods of use

Immunogenic composition for MERS coronavirus infection

Controlled delivery of TLR3 agonists in structural polymeric devices

Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants

Scaffolds for cell transplantation

Scaffolds for cell transplantation

Vaccine composition comprising an immunogenic protein and combination adjuvants for use in eliciting antigen-specific T-cell responses

Particles comprising a shell with RNA

Stabilized human immunodeficiency virus (HIV) clade C envelope (Env) trimer vaccines and methods of using same

Vectors for expression of prostate-associated antigens

Continuous Cell Programming Devices

Continuous Cell Programming Devices

Continuous cell programming devices

Branched and linear chimeric compounds, polynucleotides, uses and methods for preparation thereof

Complex containing oligonucleotide having immunopotentiating activity and use thereof

Compound and method for vaccination and immunisation

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

Lipids and compositions for the delivery of therapeutics

SPHERICAL NUCLEIC ACID-BASED CONSTRUCTS AS IMMUNOREGULATORY AGENTS

Vaccine

Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use

Efficient mucosal vaccination mediated by the neonatal Fc receptor

CD200 inhibitors and methods of use thereof

Acceleration of vector virus induced immune response in avians

Chlamydia antigens

Recombinant fusion antigen gene, recombinant fusion antigen protein and subunit vaccine composition having the same against infection of porcine reproductive and respiratory syndrome virus

Immunogenic composition in emulsion form comprising two dispersed phases, one comprising an antigen and the other comprising an immunostimulating agent

Hepatitis B vaccine

METHOD OF PROCESSING A VETERINARY TUMOR VACCINE AND A VETERINARY TUMOR VACCINE PROCESSING KIT

Gastrin peptide immunogenic composition

Immunostimulatory combinations

Nanoparticle compositions

Vaccine composition

Stabilized soluble pre-fusion RSV F polypeptides

COMPOSITIONS AND METHODS FOR PERSONALIZED NEOPLASIA VACCINES

Induction of cross-reactive cellular response against rhinovirus antigens

Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds

Allogeneic autophagosome-enriched composition for the treatment of disease

Compositions for stimulation of mammalian innate immune resistance to pathogens

Method for preparing viral particles with cyclic dinucleotide and use of said particles for inducing immune response

Identification of immunogenic mutant peptides using genomic, transcriptomic and proteomic information

Method for improving the efficacy of a survivin vaccine in the treatment of cancer

Recombinant neuraminidase and uses thereof

ANTI-TUMOR DNA VACCINE

Individualized vaccines for cancer

Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy

Prefusion RSV F proteins and their use

ENHANCEMENT OF VACCINES

Computationally optimized broadly reactive antigens for human and avian H5N1 influenza

5′-triphosphate oligoribonucleotides

Vectors and methods for genetic immunization

METHOD FOR TREATING A beta-AMYLOIDOSIS

Synthetic conjugate of CpG DNA and T-help/CTL peptide

Short oligonucleotides as vaccine adjuvants and therapeutic agents

Functional influenza virus like particles (VLPs)

Scaffolds for cell transplantation

Immunogenic compositions comprising silicified virus and methods of use

Immunologically active compositions

Vectors and methods for genetic immunization

Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses

Methods and compositions for modulating an immune response with immunogenic oligonucleotides

Dose selection of adjuvanted synthetic nanocarriers

Viral immunogenic compositions

Dengue virus vaccine composition

Immunomodulatory agent-polymeric compounds

MDR specific antibody

IN VIVO ACTIVATION OF ANTIGEN PRESENTING CELLS FOR ENHANCEMENT OF IMMUNE RESPONSES INDUCED BY VIRUS-LIKE PARTICLES

Pneumococcal vaccine containing pneumococcal surface protein A

Emulsion vaccine compositions comprising antigen and adjuvant in the aqueous phase

Adenovirus vectors

Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF MALIGNANT GLIOMAS

Methods to enhance T-cell mediated immune response

Compositions and methods for vaccination

Lipids and compositions for the delivery of therapeutics

Identification of tumor-protective epitopes for the treatment of cancers

HPV/CyaA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders

Prostate-associated antigens and vaccine-based immunotherapy regimens

Compositions and methods for antigen targeting to CD180

Anti-HER2 vaccine based upon AAV derived multimeric structures

INDIVIDUALIZED IMMUNOMODULATION THERAPY FOR NEURODEGENERATIVE DISORDERS, CNS INJURY AND AGE-RELATED DEMENTIA

HIV immune stimulating compositions comprising recombinantly expressed pili on bacteria and methods related thereto

IC31 nanoparticles

PLACENTAL VACCINATION THERAPY FOR CANCER

Prostate-specific tumor antigens and uses thereof